Artificial Intelligence | Machine Learning | Machine Perception HelixNano | Uses Nanotechnologies to Cure Genetic Diseases

Enterprise, Healthcare, Healthcare facilities & hospitals, Genetics, Biotechnology Cambridge, MA, United States

HelixNano

Artificial Intelligence | Machine Learning | Machine Perception

HelixNano | Uses Nanotechnologies to Cure Genetic Diseases

HelixNano

Healthcare, Healthcare facilities & hospitals, Genetics, Biotechnology

Cambridge, MA, United States

At HelixNano, we have spent the last two years developing cancer vaccines. Now we are adapting our synthetic biology arsenal to take on COVID-19. 

HelixNano’s ultimate mission is to build technologies that unlock a future where freedom from cancer is a fundamental human right. But right now, the fight against a global pandemic needs all scientific hands on deck. In response to this existential challenge, our team is applying its expertise to deploy a novel vaccination approach against COVID-19.

 
 

   Total Funding: $6,354,000

   Funding Stage: Funded

   Business Stage: Scaling Up

   Market: B2C

   Company Size: 1 to 25

   Founded: 2013

 
 

For AI Startup Founders

Get introduced to VC/PE/CVC investors

Get Started

For Investors at VC/PE firms

Get introduced to AI Startup founders or founders at HelixNano

 
 
 
Hannu Rajaniemi


Hannu Rajaniemi
Co-Founder & CEO

Nikolai Eroshenko


Nikolai Eroshenko
Co-Founder and CSO

 
 

HelixNano - AI Startup | AI Startup Profile Powered by Appengine AI | Appengine AI - AI Ecosystem of 12,000+ AI Startups appengine.ai HelixNano - Manage Profile

 
 
 
appengine.ai

World's Most Promising AI Startups


Pony.ai
Observe.AI
Kodiak Robotics
OpenAI
Abnormal Security
Groq
Cohere
Anthropic



World's Leading AI Ecosystem of AI Startups, Founders, Investors, and AI Professionals


Get Started